For Whom the Bell Tolls : Refining Risk Assessment for Sudden Cardiac Death

Current Cardiology Reports
Ivaylo TonchevYitschak Biton

Abstract

Sudden cardiac death is one of the most important causes of death worldwide. Advancements in medical treatment, percutaneous interventions, and device therapy (ICD and CRTD) showed consistent reduction in mortality, mainly in survivors of SCD and in patients with ischemic cardiomyopathy and depressed left ventricular function. Patients with non-ischemic cardiomyopathies, mildly reduced LV function, and channelopathies have increased risk for SCD. Identifying the subgroup of these patients before they experience life-threatening or fatal events is essential to further improve outcomes. In this review, we aimed to summarize the current knowledge for risk stratification and primary prevention, to describe the gaps in evidence, and to discuss future directions for screening and treating patients at risk for SCD. PURPOSE OF REVIEW: The purpose of this review is to provide a comprehensive description of the etiologies of sudden cardiac death, risk stratification strategies, and to describe the current medical and interventional therapies. We aimed to discuss the current gaps in our knowledge of primary prevention of SCD and to review novel approaches and interventions. RECENT FINDINGS: The incidence of SCD has decreased in the last t...Continue Reading

References

Nov 15, 1991·The American Journal of Cardiology·Y DroryM R Kramer
Aug 10, 1989·The New England Journal of Medicine·J N Ruskin
Jun 1, 1993·Journal of Cardiovascular Electrophysiology·Z BlanckM Akhtar
Nov 15, 1996·Circulation·M H LehmannD J MacNeil
Jun 5, 1997·The New England Journal of Medicine·C M SpauldingP Carli
Dec 31, 1997·The New England Journal of Medicine·UNKNOWN Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators
Jan 28, 1998·Circulation·Y FriedlanderL A Cobb
Sep 16, 1998·The American Journal of Cardiology·M J Reiter, J A Reiffel
Apr 20, 1999·Circulation·X JouvenP Ducimetière
Dec 11, 1999·Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing·H U Klein, S Reek
Mar 22, 2002·The New England Journal of Medicine·Arthur J MossUNKNOWN Multicenter Automatic Defibrillator Implantation Trial II Investigators
Jun 14, 2002·The New England Journal of Medicine·William T AbrahamUNKNOWN MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation
Feb 28, 2003·The New England Journal of Medicine·Joseph P FrolkisMichael S Lauer
Apr 2, 2003·The New England Journal of Medicine·Bertram PittUNKNOWN Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators
May 29, 2003·JAMA : the Journal of the American Medical Association·James B YoungUNKNOWN Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators
Jul 10, 2003·Journal of the American College of Cardiology·L Brent MitchellUNKNOWN AVID Investigators
Aug 20, 2003·Circulation·Michel HaïssaguerreJacques Clémenty
Sep 3, 2003·Journal of Cardiovascular Electrophysiology·Cesar Alberte, Douglas P Zipes
Nov 7, 2003·The New England Journal of Medicine·Carlo PapponeSalvatore Rosanio
Apr 20, 2004·Journal of the American College of Cardiology·Fiorenzo GaitaChristian Wolpert
May 21, 2004·The New England Journal of Medicine·Michael R BristowUNKNOWN Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators
May 21, 2004·The New England Journal of Medicine·Alan KadishUNKNOWN Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators
Sep 17, 2004·The New England Journal of Medicine·Carlo PapponeVincenzo Santinelli
Sep 24, 2004·Circulation·Bernard BelhassenSami Viskin
Oct 20, 2004·Circulation·James B YoungUNKNOWN Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) Investigators and Committees
Dec 14, 2004·The New England Journal of Medicine·Stefan H HohnloserUNKNOWN DINAMIT Investigators
Jan 22, 2005·The New England Journal of Medicine·Gust H BardyUNKNOWN Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators
Mar 9, 2005·The New England Journal of Medicine·John G F ClelandUNKNOWN Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators
Jul 21, 2005·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Antonio RavieleUNKNOWN BEST + ICD Trial Investigators
Jan 18, 2006·Journal of the American College of Cardiology·Sabine M J M StrausJacqueline C M Witteman

❮ Previous
Next ❯

Citations

Feb 2, 2021·Circulation. Genomic and Precision Medicine·Matteo VattaRobert Nussbaum

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.